SCHEMBL6744796

SCHEMBL6744796

CO/C=C(/C(=O)OC)c1ccccc1Oc1cc(N)ncn1

nearest known ligand 0.70

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
MET P08581 3/20 0.39
KDR P35968 3/20 0.38
ALOX5AP P20292 2/20 0.38
FEN1 P39748 2/20 0.38
NPC1 O15118 1/20 0.36
ALDH1A1 P00352 1/20 0.36
RAB9A P51151 1/20 0.36
BRAF P15056 1/20 0.36
MAPK14 Q16539 1/20 0.36
TNNI3K Q59H18 1/20 0.36
LMNA P02545 1/20 0.36
MAPT P10636 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
FLT1 P17948 1/20 0.36
FLT4 P35916 1/20 0.36
MAPK8 P45983 1/20 0.35
MAPK10 P53779 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6744799 1.00 MEN1 (0.40) MEN1KMT2AMETKDRALOX5AP
SCHEMBL16561719 0.92 MEN1 (0.41) MEN1KMT2AKDRNPC1ALDH1A1
SCHEMBL6743925 0.87 MEN1 (0.39) MEN1KMT2AKDRNPC1ALDH1A1
SCHEMBL31493947 0.87 SMN1; SMN2 (0.42) MEN1KMT2AKDRNPC1ALDH1A1
SCHEMBL29657093 0.87 SMN1; SMN2 (0.42) MEN1KMT2AKDRNPC1ALDH1A1
SCHEMBL6743924 0.87 MEN1 (0.39) MEN1KMT2AKDRNPC1ALDH1A1
SCHEMBL709624 0.87 SMN1; SMN2 (0.42) MEN1KMT2AKDRNPC1ALDH1A1
SCHEMBL2996165 0.87 SMN1; SMN2 (0.42) MEN1KMT2AKDRNPC1ALDH1A1
SCHEMBL22057053 0.87 MEN1 (0.39) MEN1KMT2AKDRNPC1ALDH1A1
SCHEMBL9121807 0.87 HTT (0.44) MEN1KMT2AKDRNPC1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6777412-B2 PYRIMIDIN-4-YLOXY)PHENYL)-3-METHOXYPROPENOATE DERIVATIVES SYNGENTA LIMITED (GB) 2004-08-17 US disclosed
US-20040092746-A1 Pyrimidinyloxyphenyl-3-alkoxypropenoate derivatives as pesticides CLOUGH JOHN MARTIN (GB) 2004-05-13 US disclosed
US-6613773-B2 Pyrimidinyloxyphenyl-3-alkoxypropenoates derivatives SYNGENTA LIMITED (GB) 2003-09-02 US disclosed
US-20030060626-A1 Fungicides SYNGENTA LIMITED (GB) 2003-03-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040092746-A1 Pyrimidinyloxyphenyl-3-alkoxypropenoate derivatives as pesticides DDT, SQOR, TH MEN1 2186/4885KMT2A 491/4885MET 1416/4885
US-20030060626-A1 Fungicides CYP51A1, CYP1A1, CYP1A2 MEN1 686/4885KMT2A 352/4885MET 1261/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.